Hims & Hers Health (HIMS) Net Income (2019 - 2026)
Hims & Hers Health (HIMS) reported Net Income of -$92.1 million for Q1 2026, down 286.15% on a YoY basis from $49.5 million in Q1 2025, and down 547.14% sequentially from $20.6 million in Q4 2025.
Hims & Hers Health (HIMS) Net Income (2019 - 2026) Analysis & Trends
Hims & Hers Health (HIMS) has 8 years of Net Income data on file, last reported at -$92.1 million in Q1 2026.
- For the quarter ending Q1 2026, Net Income fell 286.15% year-over-year to -$92.1 million; the trailing twelve-month figure through Mar 2026 stood at -$13.2 million (down 108.05% YoY), and the FY2025 full-year result was $128.4 million, up 1.85% from the prior year.
- Net Income retreated to -$92.1 million in Q1 2026, from $20.6 million in the prior quarter.
- In the past five years, Net Income ranged from a high of $75.6 million in Q3 2024 to a low of -$92.1 million in Q1 2026.
- A 5-year average of $4.3 million and a median of $1.2 million in 2023 frame the typical range for Net Income.
- Across the five-year window, Net Income soared 1990.36% in 2024 and slumped 286.15% in 2026, its largest moves.
- Tracing HIMS's Net Income over 5 years: stood at -$10.9 million in 2022, then surged by 111.41% to $1.2 million in 2023, then soared by 1990.36% to $26.0 million in 2024, then dropped by 20.84% to $20.6 million in 2025, then slumped by 547.14% to -$92.1 million in 2026.
- Business Quant data shows HIMS's Net Income at -$92.1 million in Q1 2026, $20.6 million in Q4 2025, and $15.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 370.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -3.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Hims & Hers Health | 7.48 Bn | 6.73 Bn | 396.79 Mn | -92.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.12 Mn |
| Dec 31, 2025 | 20.60 Mn |
| Sep 30, 2025 | 15.77 Mn |
| Jun 30, 2025 | 42.51 Mn |
| Mar 31, 2025 | 49.49 Mn |
| Dec 31, 2024 | 26.03 Mn |
| Sep 30, 2024 | 75.59 Mn |
| Jun 30, 2024 | 13.30 Mn |
| Mar 31, 2024 | 11.13 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | -7.57 Mn |
| Jun 30, 2023 | -7.16 Mn |
| Mar 31, 2023 | -10.07 Mn |
| Dec 31, 2022 | -10.91 Mn |
| Sep 30, 2022 | -18.84 Mn |
| Jun 30, 2022 | -19.68 Mn |
| Mar 31, 2022 | -16.25 Mn |
| Dec 31, 2021 | -31.16 Mn |
| Sep 30, 2021 | -15.94 Mn |
| Jun 30, 2021 | -9.15 Mn |